2018版LI-RADS在MRI上的辅助征象
本文由美国放射学会支持的肝脏影像专家制定,系统阐述2018版LI-RADS在MRI上的辅助征象,包括应用规则、定义与依据、临床MRI示例、证据与诊断性能汇总、陷阱及未来方向;辅助征象可提高置信度或调整LI-RADS类别,但升级最多至LR-4,降级最多一级,冲突时不调整类别。
要点
- 辅助征象可提高检测与定性置信度,或调整LI-RADS类别,但升级最多至LR-4,降级最多一级。
- 存在冲突辅助征象时不应调整LI-RADS类别。
- 辅助征象可见于诊断性CT、细胞外对比剂MRI或肝胆对比剂MRI,例外之一为US评估的辅助征象。
核心结论
- LI-RADS标准化肝癌风险人群的肝脏影像表现、结果解读与报告;类别分配主要基于主要影像征象,辅助征象可用于改善检测与定性、提高置信度或调整类别。
- 辅助征象分为提示一般恶性、提示HCC、提示良性三类;提示恶性或HCC者最多升级一个类别且不超过LR-4,提示良性者最多降级一个类别。
- 存在冲突辅助征象(一个或多个提示恶性与一个或多个提示良性同时存在)时,不应调整类别。
研究设计与样本
- 由肝脏影像专家制定、美国放射学会支持的LI-RADS标准解读文章,聚焦2018版在MRI上的辅助征象。
- 内容涵盖辅助征象应用规则、定义与依据及临床MRI示例、证据与诊断性能汇总、陷阱与未来方向。
诊断标准与关键数值
- 提示一般恶性或HCC的辅助征象可用于升级,最多升级一个类别且不超过LR-4。
- 提示良性的辅助征象可用于降级,最多降级一个类别。
- 存在冲突辅助征象时,类别不应调整。
- 辅助征象可见于诊断性CT、细胞外对比剂MRI或肝胆对比剂MRI,例外之一为US评估的辅助征象。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The Liver Imaging Reporting and Data System (LI-RADS) standardizes performance of liver imaging in patients at risk for hepatocellular carcinoma (HCC) as well as interpretation and reporting of the results. Developed by experts in liver imaging and supported by the American College of Radiology, LI-RADS assigns to observations categories that reflect the relative probability of benignity, HCC, or other malignancy. While category assignment is based mainly on major imaging features, ancillary features may be applied to improve detection and characterization, increase confidence, or adjust LI-RADS categories. Ancillary features are classified as favoring malignancy in general, HCC in particular, or benignity. Those favoring malignancy in general or HCC in particular may be used to upgrade by a maximum of one category up to LR-4; those favoring benignity may be used to downgrade by a maximum of one category. If there are conflicting ancillary features (ie, one or more favoring malignancy and one or more favoring benignity), the category should not be adjusted. Ancillary features may be seen at diagnostic CT, MRI performed with extracellular agents, or MRI performed with hepatobiliary agents, with the exception of one ancillary feature assessed at US. This article focuses on LI-RADS version 2018 ancillary features seen at MRI. Specific topics include rules for ancillary feature application; definitions, rationale, and illustrations with clinical MRI examples; summary of evidence and diagnostic performance; pitfalls; and future directions. ©RSNA, 2018.
引用
- Cerny M, Chernyak V, Olivié D, et al. LI-RADS Version 2018 Ancillary Features at MRI. Radiographics. 2018. PMID: 30289735. doi:10.1148/rg.2018180052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。